scorecardresearch

Pharma

CVS, Walgreens and Walmart are the three largest retail pharmacies in the country by market share.

CVS, Walmart, Walgreens agree to pay $13.8 bln to settle US opioid claims

Nov 02, 2022

The proposed settlement calls for CVS to pay $5 billion over 10 years, Walgreens to pay $5.7 billion over 15 years and Walmart to pay $3.1 billion, mostly up front.

‘Ayurveda now recognised as a traditional medicine in more than 30 countries’, says Ayush minister

‘Ayurveda now recognised as a traditional medicine in more than 30 countries’, says Ayush minister

Oct 25, 2022

Munjpara Mahendrabhai Kalubhai was speaking at the Ayurveda Day 2022 programme in New Delhi held recently where he stated that Ayush medicines are exported to more than 100 countries. To boost the products and services in the field of Ayush, export promotion council which will cater to exports globally. "

A recent Credit Suisse report said that the competition is notably from large conglomerates (RIL-Netmeds, Tata-1mg, etc.) and pharma groups (Lupin, Torrent, etc.), which would likely pour in larger investments for a longer period.

Reliance and Adani are getting into diagnostics. So are Apollo Hospitals, Tata 1mg and many others. But why?

Oct 23, 2022

Reliance Industries acquired majority stake in Netmeds for Rs 620 crore (Reliance Retail). In June 2021, Tata Digital had acquired the online pharmacy 1MG for a cash consideration of Rs 720 crore, and then launched its own diagnostics wing.

What are biosimilars and why are pharma companies so bullish on them?

Oct 23, 2022

Biosimilars, a pre-defined moonshot sector for the Indian Biopharma industry, is expected to grow over 30 per cent and above by 2047, but needs governmental reforms to burgeon, a recent Confederation of Indian Industry (CII) report said.

While there has been a slide in demand for Covid-19 vaccines, other drugs used in the management of mild, moderate and severe Covid-19 still have a healthy market.

With Covid gone as a money spinner, what are companies like Cipla, Sun Pharma and Dr Reddy's looking at?

Oct 23, 2022

There is also muted demand for the much-hyped anti-viral drug Molnupiravir, which at least 13 firms are manufacturing including Sun Pharma, Cipla, Dr. Reddy’s, and Aurobindo Pharma, among others.

CRISIL Ratings noted a trend that there is increasing competition from online pharmacy players offering tests mainly in the wellness segment of regular tests

As Covid wanes diagnostic companies stare at a large de-growth in revenues

Oct 19, 2022

Revenue of diagnostics players this fiscal may record a 5-7 per cent de-growth with growing preference for self-test kits and a sharp fall in Covid-19 and allied tests with the pandemic waning away, global analytical company CRISIL said in a report released on Wednesday.

Dawaa Dost tied up with noted pharma companies to ensure that the best quality medicines are provided at the right price.

These pharma start-ups are making medicines affordable, cutting monthly budget by half; here's how

Oct 13, 2022

Lack of access to good quality and affordable medicines has been a major challenge plaguing Indian healthcare pushing 3% of Indians into poverty every year.

The firm has not performed the quality testing of Propylene Glycol for Diethylene Glycol and Ethylene Glycol, the report said

Cough syrup maker Maiden Pharma found non-compliant to drug manufacturing laws; show cause notice issued

Oct 12, 2022

The WHO had linked four cough syrups - Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and MaGrip N Cold Syrup - manufactured by Maiden Pharma with deaths in Gambia.

Maiden Pharma row: Govt to review product quality of PLI scheme beneficiaries

Maiden Pharma row: Govt to review product quality of PLI scheme beneficiaries

Oct 10, 2022

Talking to BT, officials from the Department of Pharmaceuticals have confirmed that the DoP has asked state drug controllers to review product quality of those pharma companies who are benefiting from the PLI scheme.

The Central Drugs Standard Control Organisation initiated a probe into the case after WHO alerted that four “contaminated” and “substandard” cough syrups made by Maiden Pharmaceuticals Limited in Haryana

Maiden Pharmaceuticals: WHO-flagged firm defaulted many times in various states for producing substandard medicines

Oct 07, 2022

WHO on Wednesday issued an alert against four cough syrups made by Maiden Pharma because they contained diethylene glycol and ethylene glycol. Both chemicals can be fatal for human bodies, as per reports.

Maiden Pharma's cough syrups were, prima facie, not sold in India, say sources

Four cough syrups that killed children in Gambia are not sold in India: sources

Oct 07, 2022

Child deaths in the Gambia: The four cough syrups in question are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup.

Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants.

EXCLUSIVE: Maiden Pharma puts the ball in Indian govt's court; says will recall products when govt orders

Oct 06, 2022

Talking exclusively to BT, Maiden Pharma, which is caught in the eye of a major storm due to WHO's allegations linking company's products to children's deaths in Gambia, says it is awaiting further directions from the Indian government.

The four products named by WHO in its report are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup. -16:9

Toxic cough syrup probe: Haryana drug controller takes samples of medicines exported to Gambia

Oct 06, 2022

WHO issued alert on 4 Indian cough syrups: Earlier in the day, the Central Drugs Standard Control Organisation initiated a probe into the case after WHO alerted that four “contaminated” and “substandard” cough syrups made by Maiden Pharmaceuticals Limited in Haryana are believed to contain chemicals that are toxic and potentially fatal.

The WHO issued a medical product alert on Wednesday asking regulators to remove Maiden Pharma goods from the market.

Rash of child deaths in Gambia linked to cough syrups made in India: WHO

Oct 06, 2022

The products may have been distributed elsewhere through informal markets, but had so far been identified only in Gambia, the WHO said in its alert.

Mansukh Mandaviya, Minister of Health and Family Welfare and Chemical and Fertilizers of India

Indian medical devices industry has potential to reach $50 billion by 2030: Mansukh Mandaviya

Sep 30, 2022

The current market size of the medical devices sector in India is estimated to be $11 billion and its share in the global medical device market is estimated to be 1.5 per cent.

DGCI allows Serum Institute to export malaria vaccine to UK (Photo: The Scientist)

DGCI allows Serum Institute to export malaria vaccine to UK

Sep 29, 2022

The malaria vaccine was designed at the Jenner Institute, University of Oxford, which collaborated with the SII in 2020 to manufacture and develop the jab for large- scale supply, the sources said.

SPARC has engaged multiple US academic centres for joint development programs targeting novel biology in the area of oncology, neuro-degeneration and immunology.

Sun Pharma's innovation arm strives to complete Covid-hit clinical trials

Sep 26, 2022

SPARC focuses on discovery and research of novel drugs prioritised in three therapeutic areas i.e. oncology, neurology and immunology. According to the company, during FY22, SPARC raised $148 million to complete the ongoing clinical studies.

The CII report pointed out that the time and cost of R&D have a significant effect on the cost of the biosimilar.

Biosimilars sector to grow 30% by 2047, CII tells how

Sep 23, 2022

According to the India Bioeconomy report 2022 by the department of biotechnology, by 2025 BioPharma sector is expected to grow nearly 1.4 times to nearly $63 billion from $45 billion in 2022.

The company has forayed into the Bangladesh market with Aster Pharmacy division

Aster DM Healthcare enters Bangladesh market, to open 25 pharmacies with GD Assist

Sep 21, 2022

The company has forayed into the Bangladesh market with Aster Pharmacy division, a UAE-based pharmacy chain.

According to an internal report of the department, DoP has at least 5 posts vacant, of which, one is of the Economic Adviser and 2 of Principal Private Secretaries and one each for undersecretary and principal staff officer.

EXCLUSIVE: 65 senior positions vacant in pharmaceutical PSUs and research institutes

Sep 19, 2022

Department of Pharmaceuticals, 3 out of its 5 PSUs and research institutions combined have 65 senior positions vacant

Earlier, Federation of Medical and Sales Representatives Association of India had filed a PIL stating that the company gave over Rs 1,000 crore freebies to doctors for prescribing an irrational dose combination of Dolo-650.-16:9

Dolo-650 maker Micro labs bribed docs with Rs 1000-crore freebies? "Not Correct", concludes IPA

Sep 10, 2022

Having received complaints from medical associations, NPPA asked IPA to investigate the matter under the Uniform Code of Pharmaceutical Marketing Practices (UCPMP), following which a three-member internal committee examined the issue.